References
- Southgate L, Machado RD, Gräf S, Morrell NW.Molecular genetic framework underlying pulmonary arterial hypertension. Nat Rev Cardiol. 2020;17(2):85–95.
- Liu Y, Zhang H, Yan L, Du W, Zhang M, Chen H, Zhang L, Li G, Li J, Dong Y, et al. MMP-2 and MMP-9 contribute to the angiogenic effect produced by hypoxia/15-HETE in pulmonary endothelial cells. J Mol Cell Cardiol. 2018;121:36–50.
- Yuan K, Shamskhou EA, Orcholski ME, Nathan A, Reddy S, Honda H, Mani V, Zeng Y, Ozen MO, Wang L, et al. Loss of endothelium-derived wnt5a is associated with reduced pericyte recruitment and small vessel loss in pulmonary arterial hypertension. Circulation. 2019;139(14):1710–24.doi:https://doi.org/10.1161/CIRCULATIONAHA.118.037642.
- Singh N, Singh H, Jagavelu K, Wahajuddin M, Hanif K. Fatty acid synthase modulates proliferation, metabolic functions and angiogenesis in hypoxic pulmonary artery endothelial cells. Eur J Pharmacol. 2017;815:462–69.doi:https://doi.org/10.1016/j.ejphar.2017.09.042.
- Rabinovitch M, Guignabert C, Humbert M.Nicolls MR.Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115(1):165–75.doi:https://doi.org/10.1161/CIRCRESAHA.113.301141.
- Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, Karoubi G, Courtman DW, Zucco L, Granton J, Stewart DJ. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res. 2006;98(2):209–17.doi:https://doi.org/10.1161/01.RES.0000200180.01710.e6.
- Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaïci A, Weitzenblum E, Cordier JF, Chabot F, et al. Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay. Circulation. 2014;129(12):1332–40.doi:https://doi.org/10.1161/CIRCULATIONAHA.113.004555.
- Nw M, Db B, ten Dijke P, MJ G, Hata A, Smith J, Pb Y, Bloch KD.Targeting BMP signalling in cardiovascular disease and anaemia. Nat Rev Cardiol. 2016;13(2):106–20.doi:https://doi.org/10.1038/nrcardio.2015.156.
- Takahashi J, Orcholski M, Yuan K, De Jesus Perez V. PDGF-dependent β-catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension.FEBS. Lett. 2016;590:101–09.
- Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaȉci A, Weitzenblum E, Cordier J-F, Chabot F, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management. era.Circulation 2010;122(2):156–63.doi:https://doi.org/10.1161/CIRCULATIONAHA.109.911818.
- Hautefort A, Mendes-Ferreira P, Sabourin J, Manaud G, Bertero T, Rucker-Martin C, Riou M, Adão R, Manoury B, Lambert M, et al. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension. Circulation. 2019;139(7):932–48.doi:https://doi.org/10.1161/CIRCULATIONAHA.118.033744.
- Yan L, Cogan JD, Hedges LK, Nunley B, Hamid R, Austin ED, Yan L, Cogan JD, Hedges LK, Nunley B, et al.The Y chromosome regulates BMPR2 expression via SRY: a possible reason “Why” fewer males develop pulmonary arterial hypertension. Am J Respir Crit Care Med. 2018;198(12):1581–83.doi:https://doi.org/10.1164/rccm.201802-0308LE.
- Long L, Ormiston ML, Yang X, Southwood M, Gräf S, Machado RD, Mueller M, Kinzel B, Yung LM, Wilkinson JM, et al.Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension. Nat Med. 2015;21(7):777–85.doi:https://doi.org/10.1038/nm.3877.
- Rabinovitch M.Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest. 2012;122(12):4306–13.doi:https://doi.org/10.1172/JCI60658.
- Wu FJ, Lin TY, Sung LY, Chang WF, Wu PC, Luo CW.BMP8A sustains spermatogenesis by activating both SMAD1/5/8 and SMAD2/3 in spermatogonia. Sci Signal. 2017;10(477):477.doi:https://doi.org/10.1126/scisignal.aal1910.
- Atkinson C, Stewart S, Upton PD, Machado R, Thomson JR, Trembath RC, Morrell NW.Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation. 2002;105(14):1672–78.doi:https://doi.org/10.1161/01.CIR.0000012754.72951.3D.
- Dewachter L, Adnot S, Guignabert C, Tu L, Marcos E, Fadel E, Humbert M, Dartevelle P, Simonneau G, Naeije R, et al.Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension. Eur Respir J. 2009;34(5):1100–10.doi:https://doi.org/10.1183/09031936.00183008.
- Zhang Y, Wang Y, Yang K, Tian L, Fu X, Wang Y, Sun Y, Jiang Q, Lu W, Wang J.BMP4 increases the expression of TRPC and basal [Ca2+] i via the p38MAPK and ERK1/2 pathways independent of BMPRII in PASMCs. PLoS One. 2014;9(12):e112695.doi:https://doi.org/10.1371/journal.pone.0112695.
- La H, Dunmore BJ, Long L, Crosby A, Al-Lamki R, Deighton J, Southwood M, Yang X, Nikolic MZ, Herrera B, et al. TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling. Nat Commun. 2017;8(1):14079.doi:https://doi.org/10.1038/ncomms14079.
- Yang P, Moore S, Crosby A, Soon E, Jones FM, Southwood MR, Haghighat L, Toshner MR, Raine T, Horan I, et al. Hepatic shunting of eggs and pulmonary vascular remodeling in Bmpr2(±) mice with schistosomiasis. 24. Am J Respir Crit Care Med. 2015;192(11):1355–65. doi:https://doi.org/10.1164/rccm.201412-2262OC
- Ormiston ML, Godoy RS, Chaudhary KR, Stewart DJ. The janus faces of bone morphogenetic protein 9 in pulmonary arterial hypertension. Circ Res. 2019;124(6):822–24. 15. doi:https://doi.org/10.1161/CIRCRESAHA.119.314753.
- Lowery JW, Frump AL, Anderson L, Di Carlo GE, Jones MT, de Caestecker MP.ID family protein expression and regulation in hypoxic pulmonary hypertension. Am J Physiol Regul Integr Comp Physiol. 2010;299(6):R1463–R1477.doi:https://doi.org/10.1152/ajpregu.00866.2009.
- Maruyama H, Dewachter C, Belhaj A, Rondelet B, Sakai S, Remmelink M, Vachiery JL, Naeije R, Dewachter L.Endothelin-bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension. J Heart Lung Transplant. 2015;34(3):468–78.doi:https://doi.org/10.1016/j.healun.2014.09.011.
- Cm C, Howell K, Cahill E, McBryan J, Konigshoff M, Eickelberg O, Gaine S, Martin F, McLoughlin P.Lungselective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2008;295(2):L272–L284.doi:https://doi.org/10.1152/ajplung.00358.2007.
- Murphy N, Gaynor KU, Rowan SC, Walsh SM, Fabre A, Boylan J, Keane MP, McLoughlin P.Altered expression of bone morphogenetic protein accessory proteins in murine and human pulmonary fibrosis. Am J Pathol. 2016;186(3):600–15.doi:https://doi.org/10.1016/j.ajpath.2015.10.032.
- Singhatanadgit W, Salih V.Olsen. Bone morphogenetic protein receptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-alpha in human bone cells. Int J Biochem Cell Biol. 2006;38(10):1794–807.doi:https://doi.org/10.1016/j.biocel.2006.05.005.
- Cw K, Song H, Kumar S, Nam D, Kwon HS, Chang KH, Son DJ, Kang D-W, Brodie SA, Weiss D, et al. Anti-inflammatory and antiatherogenic role of BMP receptor II in endothelial cells. Arterioscler Thromb Vasc Biol. 2013;33(6):1350–59.doi:https://doi.org/10.1161/ATVBAHA.112.300287.
- Yu PB, Deng DY, Beppu H, Hong CC, Lai C, Hoyng SA, Kawai N, Bloch KD. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells. J Biol Chem. 2008;283(7):3877–88.doi:https://doi.org/10.1074/jbc.M706797200.
- Cai P, Kovacs L, Dong S, Wu G, Su Y.BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2017;312(5):L638–L648.doi:https://doi.org/10.1152/ajplung.00260.2016.
- Dorfmüller P, Humbert M, Perros F, Sanchez O, Simonneau G, Müller KM, Capron F, Capron F.Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol. 2007;38(6):893–902.doi:https://doi.org/10.1016/j.humpath.2006.11.022.
- Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, Trembath RC, Jennings S, Barker L, Nicklin P, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension.Circulation. 2010; 122:920–27.
- Courboulin A, Barrier M, Perreault T, Bonnet P, Tremblay VL, Paulin R, Tremblay E, Lambert C, Jacob MH, Bonnet SN, et al.Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH. Eur Respir J. 2012;40(3):618–29.doi:https://doi.org/10.1183/09031936.00084211.
- Crosby A, Soon E, Jones FM, Southwood MR, Haghighat L, Toshner MR, Raine T, Horan I, Yang P, Moore S, et al. Hepatic shunting of eggs and pulmonary vascular remodeling in Bmpr2(+/−) mice with schistosomiasis. Am J Respir Crit Care Med 2015;192:1355–65.
- Nie X, Tan J, Dai Y, Liu Y, Zou J, Sun J, Ye S, Shen C, Fan L, Chen J, et al. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation. J Mol Cell Cardiol. 2018;116:41–56.
- Gomez-Puert O, Van Zuijen I, Huang CJ, Szulcek R, Pan X, Ma VD, Kurakula K, Wiesmeijer CC, Goumans M-J, Bogaard H-J, et al. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.J. Pathol. 2019;2493:356–67.https://doi.org/10.1002/path.5322
- Ca F, Jones ML, Bernabeu MO, Vion AC, Barbacena P, Fan J, Mathivet T, Fonseca CG, Ragab A, Yamaguchi TP, et al. Non-canonical Wnt signalling modulates the endothelial shear stress flow sensor in vascular remodelling. ELife. 2016;5:e07727.
- Arciniegas E, Frid MG, Douglas IS, Stenmark KR.Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2007;293(1):L1–L8.doi:https://doi.org/10.1152/ajplung.00378.2006.
- Willis BC, Borok Z.TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol. 2007;293(3):L525–L534.doi:https://doi.org/10.1152/ajplung.00163.2007.
- TP A, Li M, Perez Vde J, Pham D, Sawada H, Wang JK, Koskenvuo M, Wang L, Freeman BA, Chang HY, et al.Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. J Clin Invest. 2011;121(9):3735–46.doi:https://doi.org/10.1172/JCI43382.
- Li L, Wei C, Kim IK, Janssen-Heininger Y, Gupta S.Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice. Hypertension. 2014;63(6):1260–69.doi:https://doi.org/10.1161/HYPERTENSIONAHA.114.03220.
- Yy W, Luan Y, Zhang X, Lin M, Zhang ZH, Zhu XB, Ma Y, Wang YB.Proteasome inhibitor PS-341 attenuates flow-induced pulmonary arterial hypertension. Clin Exp Med. 2014;14(3):321–29.doi:https://doi.org/10.1007/s10238-013-0244-7.
- Sauteur L, Krudewig A, Herwig L, Ehrenfeuchter N, Lenard A, Affolter M, H-g B.Cdh5/VE-cadherin promotes endothelial cell interface elongation via cortical actin polymerization during angiogenic sprouting. Cell Reports. 2014;9(2):504–13.doi:https://doi.org/10.1016/j.celrep.2014.09.024.
- Bentley K, Franco CA, Philippides A, Blanco R, Dierkes M, Gebala V, Stanchi F, Jones M, Aspalter IM, Cagna G, et al.The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nature Cell Biology. 2014;16(4):309–21.doi:https://doi.org/10.1038/ncb2926.
- Ehling M, Adams S, Benedito R, Adams RH.Notch controls retinal blood vessel maturation and quiescence. Development. 2013;140(14):3051–61.doi:https://doi.org/10.1242/dev.093351.
- Lobov IB, Cheung E, Wudali R, Cao J, Halasz G, Wei Y, Economides A, Lin HC, Papadopoulos N, Yancopoulos GD, et al.The Dll4/Notch pathway controls postangiogenic blood vessel remodeling and regression by modulating vasoconstriction and blood flow. Blood. 2011;117(24):6728–37.doi:https://doi.org/10.1182/blood-2010-08-302067.
- De C, Breckenridge MT, Hinde E, Gratton E, Chen CS, Schwartz MA.Fluid shear stress on endothelial cells modulates mechanical tension across VE-cadherin and PECAM-1. Current Biology. 2013;23(11):1024–30.doi:https://doi.org/10.1016/j.cub.2013.04.049.
- Vitorino P, Meyer T.Modular control of endothelial sheet migration. Genes & Development. 2008;22(23):3268–81.doi:https://doi.org/10.1101/gad.1725808.
- Yu XM, Wang L, Li JF, Liu J, Li J, Wang W, Wang J, Wang C. Wnt5ainhibits hypoxia-induced pulmonary arterial smooth muscle cell proliferation by downregulationof β-catenin. Am J Physiol Lung Cell Mol Physiol. 2013;304(2):L103–L111.doi:https://doi.org/10.1152/ajplung.00070.2012.
- Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E, Konstantinou G, Sdrimas K, Fernandez-Gonzalez A, Kourembanas S. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation. 2012;126(22):2601–11.doi:https://doi.org/10.1161/CIRCULATIONAHA.112.114173.
- Jin Y, Wang W, Chai S, Liu J, Yang T, Wang J.Wnt5a attenuates hypoxia-induced pulmonary arteriolar remodeling and right ventricular hypertrophy in mice. Exp Biol Med (Maywood). 2015;240(12):1742–51.doi:https://doi.org/10.1177/1535370215584889.
- Vuga LJ, Ben-Yehudah A, Kovkarova-Naumovski E, Oriss T, Gibson KF, Feghali-Bostwick C, Kaminski N. WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Am J Respir Cell Mol Biol. 2009;41(5):583–89.doi:https://doi.org/10.1165/rcmb.2008-0201OC.
- Kumawat K, Gosens R.WNT-5A: signaling and functions in health and disease.Cell Mol Life Sci,2016.73(3):567–87.doi:https://doi.org/10.1007/s00018-015-2076-y.
- Vinicio A, De Jesus P, Alastalo T-P, Wu JC, et al. Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. J Cell Biol. 2009;184:83–99.
- Tu L, Desroches-Castan A, Mallet C, Guyon L, Cumont A, Phan C, Robert F, Thuillet R, Bordenave J, Sekine A, et al. Selective BMP-9 inhibition partially protects against experimental pulmonary hypertension. Circ Res. 2019;124(6):846–55. 15. doi:https://doi.org/10.1161/CIRCRESAHA.118.313356.
- Zhang S, Liu X, Ge LL, Li K, Sun Y, Wang F, Han Y, Sun C, Wang J, Jiang W, et al.Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling. Respir Res. 2020;21(1):71.doi:https://doi.org/10.1186/s12931-020-1331-4.
- Zhang Z, Ge L, Zhang S, Wang J, Jiang W, Xin Q, Luan Y.The protective effects of MSC-EXO against pulmonary hypertension through regulating Wnt5a/BMP signalling pathway.J. Cell Mol Med. 2020;24(23):13938–48.doi:https://doi.org/10.1111/jcmm.16002.
- Korn C, Scholz B, Hu J, et al. Endothelial cell-derived non-canonical Wnt ligands control vascular pruning in angiogenesis.Development. 2014;141:1757–66.